论文信息 - Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR? - 字舞流文

Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?

F. Rivera | M. Salgado | C. Pericay | A. Ruiz-Casado | R. Vera | M. Safont | P. Escudero | V. Alonso | I. Juez | E. González | C. López | E. Mata | P. Iranzo | N. Martínez | J. Cabrera | B. González